Cutis laxa

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:209
Who is this for?
Show terms as
32Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Cutis laxa is a heterogeneous group of rare connective tissue disorders characterized by loose, redundant, and inelastic skin that hangs in folds, giving an aged appearance. The condition results from defects in elastic fiber formation, assembly, or maintenance. Cutis laxa can be inherited or acquired, and the inherited forms include autosomal dominant cutis laxa (ADCL), autosomal recessive cutis laxa (ARCL types 1, 2, and 3), and X-linked cutis laxa (also known as occipital horn syndrome). The disease affects multiple body systems beyond the skin, including the lungs (emphysema), cardiovascular system (aortic aneurysms, arterial tortuosity), gastrointestinal tract (diverticulae, hernias), and urogenital system (bladder diverticula). Skeletal abnormalities, developmental delay, and growth retardation may also occur, particularly in the autosomal recessive forms. The severity varies considerably depending on the genetic subtype. Autosomal dominant cutis laxa, often caused by mutations in the ELN (elastin) gene, tends to be milder with primarily cutaneous and pulmonary involvement. Autosomal recessive forms, associated with mutations in genes such as FBLN5, FBLN4 (EFEMP2), LTBP4, ATP6V0A2, PYCR1, ATP6V1E1, and others, are generally more severe and can be life-threatening in infancy due to cardiopulmonary complications. X-linked cutis laxa, caused by mutations in ATP7A, involves copper metabolism abnormalities and features skeletal anomalies including occipital exostoses. There is currently no cure for cutis laxa. Treatment is supportive and multidisciplinary, focusing on managing complications in affected organ systems. Surgical repair may be considered for hernias, and plastic surgery can address cosmetically significant skin laxity, although results may be temporary. Pulmonary and cardiovascular monitoring is essential. Genetic counseling is recommended for affected families to clarify the specific subtype and recurrence risk.

Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗NORD ↗

FDA & Trial Timeline

10 events
Oct 2026Prospective Clinical Investigation to Evaluate the Safety and Effectiveness of Juläine™ in Improving Gluteal Skin Laxity in Adults.

Nordberg Medical AB — NA

TrialNOT YET RECRUITING
Mar 2026Assess Efficacy of a Nanodiamond Periprocedural Skin Care Regimen for Ablative Resurfacing

Goldman, Butterwick, Fitzpatrick and Groff — PHASE2

TrialNOT YET RECRUITING
Mar 2026Assess Injectable Hyaluronic Acid Gel for the Treatment of Volume Loss, Skin Laxity and Fine Lines

Goldman, Butterwick, Fitzpatrick and Groff — PHASE4

TrialNOT YET RECRUITING
Mar 2026Prospective Clinical Evaluation of the Safety and Performance of the Aesthetic Medical Device MEC REGENERATE® (Injectable Recombinant Collagen-based Product)

303 Pharma s.r.l. — NA

TrialNOT YET RECRUITING
Feb 2026Micro-Coring® for the Treatment of Skin Laxity of the Knees

Cytrellis Biosystems, Inc. — NA

TrialENROLLING BY INVITATION
Feb 2026RESTRUCTURING THE MANDIBULAR ANGLE IN FACIAL AGING: A NOVEL TECNIQUE USING POLY-L-LACTIC ACID

Doris Hexsel — NA

TrialNOT YET RECRUITING
Feb 2026Pre-marketing Trial to Assess Safety and Efficacy of 'Volumizing Filler Based on Hyaluronic Acid and Recombinant Collagen'

Taumedika s.r.l. — NA

TrialRECRUITING
Dec 2025Comparative Study of Ziplyft Treatment vs. Traditional Blepharoplasty for Upper Eyelid Rejuvenation

Osheru Inc. — NA

TrialRECRUITING
Nov 2025Assess Impact of Microdroplet Hyaluronic Acid Filler on Skin Quality in Patients on Glucagon-like Peptide-1 Agonists

Goldman, Butterwick, Fitzpatrick and Groff — PHASE2

TrialNOT YET RECRUITING
Nov 2025Safety and Efficacy of 2910 nm Fiber Laser Resurfacing and Laser-Coring

FA Corporation — NA

TrialNOT YET RECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

No FDA-approved treatments are currently listed for Cutis laxa.

View clinical trials →

No actively recruiting trials found for Cutis laxa at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Cutis laxa community →

Specialists

Showing 25 of 32View all specialists →
MM
Murad Alam, MD
CHICAGO, IL
Specialist
PI on 14 active trials
DM
Daryousch Parvizi, MD
Specialist
PI on 1 active trial
JM
Jeffrey Dover, MD
CHESTNUT HILL, MA
Specialist
PI on 2 active trials
EM
Edward Lain, MD, MBA
AUSTIN, TX
Specialist
PI on 2 active trials
RM
Ruthie Amir, MD
Specialist
PI on 4 active trials
JP
Jenna Macciochi, PhD
Specialist
PI on 1 active trial
ME
Merz Medical Expert
Specialist
PI on 9 active trials
BC
Becky Clarke
Specialist
PI on 1 active trial22 Cutis laxa publications
MP
Michail M Pankratov, MD, PhD
Specialist
PI on 1 active trial
MG
Mathew Gronski
Specialist
PI on 1 active trial
GM
Gordon Sasaki, MD
PASADENA, CA
Specialist
PI on 3 active trials1 Cutis laxa publication
CM
Cameron K Rokhsar, MD
NEW YORK, NY
Specialist
PI on 1 active trial
AM
Aris Sterodimas, MD
Specialist
PI on 1 active trial1 Cutis laxa publication
RE
Rania Elhawary
Specialist
PI on 1 active trial13 Cutis laxa publications
RM
Robin McIntosh
GASTONIA, NC
Specialist
PI on 2 active trials4 Cutis laxa publications
JC
Jennifer Civiok
Specialist
PI on 3 active trials
JM
James Namnoum, MD
ATLANTA, GA
Specialist
PI on 1 active trial
JM
Jay Burns, MD
Specialist
PI on 2 active trials
DM
David Goldberg, MD
Specialist
PI on 2 active trials
TF
Toni Fournier
Specialist
PI on 1 active trial5 Cutis laxa publications
BM
Barry DiBernardo, MD
MONTCLAIR, NJ
Specialist
PI on 1 active trial
DM
David Holcomb, M.D.
Specialist
PI on 1 active trial
MM
Melinda Lacerna, M.D.
Specialist
PI on 1 active trial

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Cutis laxa.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Cutis laxaForum →

No community posts yet. Be the first to share your experience with Cutis laxa.

Start the conversation →

Latest news about Cutis laxa

Disease timeline:

New recruiting trial: An Evaluation of the Erchonia Laser As a Non-Invasive Treatment to Improve the Appearance of Skin Laxity

A new clinical trial is recruiting patients for Cutis laxa

New recruiting trial: Pure Impact Treatment to Strengthen and Tone Abdomen, Quadriceps and Glutes Muscles

A new clinical trial is recruiting patients for Cutis laxa

New recruiting trial: A Prospective Controlled Study to Evaluate the Safety and Effectiveness of Thermage® FLX Radiofrequency Treatment

A new clinical trial is recruiting patients for Cutis laxa

New recruiting trial: Treatment to Lift Facial Lax Skin and Improve Facial Wrinkles Using Precise and Lift Applicators

A new clinical trial is recruiting patients for Cutis laxa

New recruiting trial: Association of Leucocyte Telomere Length With DPAS Score in Skin Aging

A new clinical trial is recruiting patients for Cutis laxa

New recruiting trial: Effects of QUANTUM Probe for Skin Rejuvenation and Subdermal Retraction in Patients Undergoing High-Definition Liposculpture

A new clinical trial is recruiting patients for Cutis laxa

New recruiting trial: Ellacor® Micro-Coring Technology® in Fitzpatrick Skin Types I-VI, Including Patients Receiving Glucagon-Like Peptide-1 Receptor Agonists

A new clinical trial is recruiting patients for Cutis laxa

New recruiting trial: Safety and Effectiveness Evaluation of the High-intensity Focused Ultrasound Device for Lifting Lax Submental and Neck Tissue

A new clinical trial is recruiting patients for Cutis laxa

New recruiting trial: A Study to Characterize Human Skin Changes From Biostimulator Treatments Via Non-invasive Imaging

A new clinical trial is recruiting patients for Cutis laxa

New recruiting trial: Pre-marketing Trial to Assess Safety and Efficacy of 'Volumizing Filler Based on Hyaluronic Acid and Recombinant Collagen'

A new clinical trial is recruiting patients for Cutis laxa

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Cutis laxa

What is Cutis laxa?

Cutis laxa is a heterogeneous group of rare connective tissue disorders characterized by loose, redundant, and inelastic skin that hangs in folds, giving an aged appearance. The condition results from defects in elastic fiber formation, assembly, or maintenance. Cutis laxa can be inherited or acquired, and the inherited forms include autosomal dominant cutis laxa (ADCL), autosomal recessive cutis laxa (ARCL types 1, 2, and 3), and X-linked cutis laxa (also known as occipital horn syndrome). The disease affects multiple body systems beyond the skin, including the lungs (emphysema), cardiovascul

Which specialists treat Cutis laxa?

25 specialists and care centers treating Cutis laxa are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.